BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Amieva-Balmori M, Mejia-Loza SMI, Ramos-González R, Zamarripa-Dorsey F, García-Ruiz E, Pérez y López N, Juárez-Valdés EI, López-Luria A, Remes-Troche JM. Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best? World J Hepatol 2015; 7(17): 2119-2126 [PMID: 26301054 DOI: 10.4254/wjh.v7.i17.2119]
URL: https://www.wjgnet.com/1948-5182/full/v7/i17/2119.htm
Number Citing Articles
Khushboo S. Gala, Vatsalya Vatsalya. Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and ScopeCells 2020; 9(3): 524 doi: 10.3390/cells9030524
G. Liamis, T. D. Filippatos, A. Liontos, M. S. Elisaf. Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromiseHepatology International 2016; 10(5): 762 doi: 10.1007/s12072-016-9746-1
O. S. Pershenkova, E. I. Mikhailova. Diagnostic stigmas of alcoholic liver diseaseHealth and Ecology Issues 2023; 20(2): 7 doi: 10.51523/2708-6011.2023-20-2-01
Betty P. Morales, Ramon Planas, Ramon Bartoli, Rosa M. Morillas, Margarita Sala, Eduard Cabré, Irma Casas, Helena Masnou. Early hospital readmission in decompensated cirrhosis: Incidence, impact on mortality, and predictive factorsDigestive and Liver Disease 2017; 49(8): 903 doi: 10.1016/j.dld.2017.03.005
Kris Bennett, Doyo G. Enki, Mark Thursz, Matthew E. Cramp, Ashwin D. Dhanda. Systematic review with meta‐analysis: high mortality in patients with non‐severe alcoholic hepatitisAlimentary Pharmacology & Therapeutics 2019; 50(3): 249 doi: 10.1111/apt.15376